Ravi Anand

About

Ravi Anand is an Assistant Professor of Psychiatry and Behavioral Sciences at Duke University. He is part of the Child & Family Mental Health & Community Psychiatry Division. His professional role involves contributing to the academic and clinical missions of the department, with a focus on mental health and community psychiatry. Further details about his research interests, background, and specific contributions are not provided on the page.

Research topics

• Medicine
• Internal medicine
• Environmental health
• Surgery
• Pediatrics
• Demography
• Anesthesia

Selected publications

• Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling

  Clinical Pharmacokinetics · 2021-10-07 · 38 citations

  articleOpen access

  BACKGROUND AND OBJECTIVE: While one in five children in the USA are now obese, and more than three-quarters receive at least one drug during childhood, there is limited dosing guidance for this vulnerable patient population. Physiologically based pharmacokinetic modeling can bridge the gap in the understanding of how pharmacokinetics, including drug distribution and clearance, changes with obesity by incorporating known obesity-related physiological changes in children. The objective of this stu…

  PublisherOA PDFDOI

• Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants

  Clinical Pharmacokinetics · 2021-06-22 · 33 citations

  articleOpen access
  PublisherOA PDFDOI

• Prolonged Post-Discontinuation Antibiotic Exposure in Very Low Birth Weight Neonates at Risk for Early-Onset Sepsis

  Journal of the Pediatric Infectious Diseases Society · 2020-12-28 · 11 citations

  articleOpen access

  BACKGROUND: Premature, very low birth weight (VLBW) neonates are at risk for early-onset sepsis and receive ampicillin and gentamicin post-birth. Antimicrobial stewardship supports short-course antibiotics, but how long antibiotic concentrations remain therapeutic post-last dose is unknown. METHODS: Using Monte Carlo simulations (NONMEM 7.3), we analyzed antibiotic exposures in a retrospective cohort of 34 689 neonates (<1500 g, 22-27 weeks of gestation). Therapeutic exposure for ampicillin and…

  PublisherOA PDFDOI

• Furosemide Safety in Preterm Infants at Risk for Bronchopulmonary Dysplasia: A Randomized Clinical Trial

  UNC Libraries · 2026-04-29

  articleOpen access
  PublisherDOI

• Corrigendum to “Furosemide Safety in Preterm Infants at Risk for Bronchopulmonary Dysplasia: A Randomized Clinical Trial” J Pediatr. 2025 Apr 28;283:114629

  UNC Libraries · 2026-04-29

  articleOpen access
  PublisherDOI

Frequent coauthors

• Daniel K. Benjamin

  Duke University

  121 shared

• P. Brian Smith

  119 shared

• Michael Cohen‐Wolkowiez

  Clinical Research Institute

  118 shared

• Lisa Castro

  105 shared

• Beverly Brozanski

  St. Louis Children's Hospital

  97 shared

• John C. Bucuvalas

  Icahn School of Medicine at Mount Sinai

  73 shared

• Rita Vassena

  72 shared

• P. De Sutter

  66 shared

Similar researchers at Duke University

• Hayden Barry Bosworthh-109
• Jean Crowell Beckhamh-104
• Melanie Jean Bonnerh-57